Results 81 to 90 of about 15,436 (169)

TRANSTHYRETIN CARDIAC AMYLOIDOSIS REVEALED BY MULTIMODALITY IMAGING IN AN ELDERLY PATIENT WITH HFpEF

Tạp chí Sức khỏe và Lão hóa (Journal of Health and Aging)
Amyloid cardiomyopathy is an infiltrative disease caused by extracellular deposition of amyloid fibrils within the myocardium, most commonly from immunoglobulin light-chain (AL) or transthyretin (ATTR) sources, leading to progressive heart failure ...
Le Quoc Hung, Tran Trong Phu, Nguyen Van Be Hai, Tran Huong Tra My, Nguyen Van Te   +4 more
doaj   +1 more source

Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy

JAMA Cardiology
ImportanceTransthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive cardiomyopathy that commonly presents with concomitant chronic kidney disease. Chronic kidney dysfunction is associated with worse outcomes, but the prognostic value of changes in kidney function over time has yet to be defined.ObjectiveTo assess the prognostic importance of a ...
Ioannou, Adam, Razvi, Yousuf, Porcari, Aldostefano, Rauf, Muhammad U., Martinez-Naharro, Ana, Venneri, Lucia, Kazi, Salsabeel, Pasyar, Ali, Luxhøj, Carina M., Petrie, Aviva, Moody, William, Steeds, Richard P., Sperry, Brett W., Witteles, Ronald M., Whelan, Carol, Wechalekar, Ashutosh, Lachmann, Helen, Hawkins, Philip N., Solomon, Scott D., Gillmore, Julian D., Fontana, Marianna   +20 more
openaire   +2 more sources

Tissue Screening and Diagnosis of Transthyretin Amyloid Cardiomyopathy. [PDF]

Rev Cardiovasc Med
Tang R, Patolia H, Shukla N, Rajendran J, El Helou MC, Agdamag A, Estep JD, Rubio AC, Hanna M, Martyn T.   +9 more
europepmc   +1 more source

A Hemodynamic Echocardiographic Approach to Disease Severity and Prognosis in Transthyretin Amyloid Cardiomyopathy. [PDF]

JACC Adv
Serenelli M, Cantone A, Porcari A, Pozzan M, Merlo M, Sinagra G, Guidi Colombi G, Dal Passo B, Sanguettoli F, Arzenton M, Maio D, Vitali M, Casolari G, Bonini J, Cipriani A, De Michieli L, Mele D, Sinigiani G, Tomasoni D, Metra M, Pavasini R, Biscaglia S, Campo G.   +22 more
europepmc   +1 more source

Amyloid Cardiomyopathy Mimicking Reverse Takotsubo Cardiomyopathy [PDF]

Heart, Lung and Circulation, 2016
O. Gibbs, J. Otton, A. Makris, J. French
openaire   +1 more source

A case of repeated misdiagnosis of amyloid cardiomyopathy

Indian Journal of Medical Research, 2021
Feng, Xiang-Fei, Zhou, Qing
openaire   +2 more sources

Stage-dependent timing of relative and absolute treatment benefit in transthyretin amyloid cardiomyopathy. [PDF]

Open Heart
Nabeshima Y, Kaneko T, Yajima A, Node K, Takeuchi M.   +4 more
europepmc   +1 more source

Sex Differences in Presentation and Outcomes of Transthyretin Amyloid Cardiomyopathy. [PDF]

JACC Adv
Ciocca N, Fuentes Artiles R, Studer Bruengger A, Hugelshofer S, Stämpfli SF, Ehl NF, Pieczora L, Suter A, Pongan D, Ministrini S, Pfister O, Meyer P, Shiri I, Hunziker L, Hundertmark MJ, Gräni C.   +15 more
europepmc   +1 more source

Impact of amyloid cardiomyopathy diagnosis on heart failure readmission and length of stay. [PDF]

Proc (Bayl Univ Med Cent)
Masri AF, Vardar U, Jabbar U, Murthi M, Malhotra S.   +4 more
europepmc   +1 more source

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Heart Fail
Testani JM, Judge DP, Borlaug BA, Cherney D, Cox ZL, Gillmore JD, Lewis JB, Adler SH, Cao X, Castaño A, Fox JC, Katz L, Mathur V, Xiong K, Butler J, Masri A.   +15 more
europepmc   +1 more source